San Ramon, CA, United States of America

Jan Johansson

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 66(Granted Patents)


Location History:

  • Milpitas, CA (US) (2008)
  • Portola Valley, CA (US) (2013)
  • Danville, CA (US) (2013 - 2015)
  • San Ramon, CA (US) (2016 - 2022)

Company Filing History:


Years Active: 2008-2022

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations by Inventor Jan Johansson in Cholesterol Management

Introduction

Jan Johansson, an accomplished inventor based in San Ramon, California, has made significant contributions to the field of biomedical sciences. With a portfolio of 8 patents, Johansson has focused on developing innovative peptides that address critical health issues related to cholesterol levels and various metabolic disorders. His work exemplifies the intersection of science and practical applications in improving health outcomes.

Latest Patents

Among his latest inventions, Johansson has developed a family of non-naturally occurring polypeptides that exhibit cholesterol efflux activity comparable to that of full-length apolipoproteins such as Apo AI and Apo E. These peptides demonstrate high selectivity for the ABCA1 receptor and are notable for their significantly reduced toxicity, even when administered at therapeutic and higher doses. The implications of this invention extend to the treatment, prevention, and diagnosis of diseases and disorders associated with dyslipidemia, hypercholesterolemia, inflammation, and metabolic conditions such as diabetes and Alzheimer's Disease.

Career Highlights

Jan Johansson has been affiliated with notable institutions, including the University of California and Resverlogix Corporation. His tenure at these organizations has allowed him to spearhead groundbreaking research, contributing to a deeper understanding of cholesterol management and metabolic health.

Collaborations

In his journey as an inventor, Johansson has worked alongside colleagues like John K. Bielicki and Waleed Danho, collaborating to create innovative solutions that validate the importance of teamwork in the scientific research community.

Conclusion

Jan Johansson's inventive spirit continues to drive forward the field of cholesterol management and metabolic health. His contributions not only enhance our understanding of health-related challenges but also pave the way for new therapeutic approaches that can potentially transform patient care. With his ongoing research and innovations, Johansson remains a key figure in the quest for advanced health solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…